Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks

Journal of Infectious Diseases

Volumn 209, Issue 11, 2014, Pages 1693-1699

  Troy, Stephanie B ^a   Ferreyra Reyes, Leticia ^b   Huang, Chunhong ^c   Sarnquist, Clea ^c   Canizales Quintero, Sergio ^b   Nelson, Christine ^a   Báez Saldaña, Renata ^b   Holubar, Marisa ^c   Ferreira Guerrero, Elizabeth ^b   García García, Lourdes ^b   Maldonado, Yvonne A ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

inactivated polio vaccine; Mexico; oral polio vaccine; polio; VDPV

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FECES ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; MALE; MASS IMMUNIZATION; MEXICO; MIDDLE AGED; NATIONAL IMMUNIZATION WEEK; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHOOL CHILD; SEROTYPE; VIRUS ISOLATION; VIRUS TRANSMISSION; YOUNG ADULT;

INACTIVATED POLIO VACCINE; MEXICO; ORAL POLIO VACCINE; POLIO; VDPV;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEXICO; NATIONAL HEALTH PROGRAMS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RURAL POPULATION; URBAN POPULATION; VIRUS SHEDDING; YOUNG ADULT;

EID: 84900561103     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit831     Document Type: Article

References (24)

1. Global Polio Eradication Initiative. Available at: http://www.polioeradi cation.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 9 September 2013.
2. Minor P, Macadam A, Stone D, Almond J. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 1993; 21: 357-63.
3. Troy S, Maldonado Y. Polioviruses. In: Long SS, Pickering LK, Prober CG, ed. Principles and practice of pediatric infectious diseases. 4th ed. China: Elsevier Inc., 2012.
4. (CDC) CfDCaP. Update on vaccine-derived polioviruses - worldwide, april 2011-june 2012. MMWR Morb Mortal Wkly Rep 2012; 61: 741-6.
5. Global Polio Eradication Initiative. Available at: http://www.polioeradi cation.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederived poliovirus.aspx. Accessed 20 November 2013.
6. Jenkins H, Aylward R, Gasasira A, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010; 362: 2360-9.
7. WorldHealthOrganization(WHO).PolioEradication&EndgameStrategic Plan 2013-2018: Executive Summary. Geneva, Switzerland: WHO Press, 2013.
8. INEGI (Instituto Nacional de Estadística G, e Informática). XIII Censo General de Población y Vivienda 2010. Mexico, 2011.
9. Troy SB, Ferreyra-Reyes L, Canizales-Quintero S, et al. Real-time polymerase chain reaction analysis of sewage samples to determine oral polio vaccine circulation duration and mutation after Mexican National ImmunizationWeeks. J Pediatric Infect Dis Soc 2012; 1: 223-9.
10. Troy SB, Musingwini G, Halpern MS, et al. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. J Infect Dis 2013; 208: 672-8.
11. Troy SB, Ferreyra-Reyes L, Huang C, et al. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a Mexican national immunization day. J Clin Microbiol 2011; 49: 1777-83.
12. Más Lago P, Gary HJ, Pérez L, et al. Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. Int J Epidemiol 2003; 32: 772-7.
13. Huang Q, Greening G, Baker M, et al. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 2005; 366: 394-6.
14. Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120140.
15. Fine PE, Carneiro IA. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 1999; 150: 1001-21.
16. Benyesh-Melnick M, Melnick JL, Rawls WE, et al. Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol 1967; 86: 112-36.
17. Horstmann DM, Paul JR, Godenne-Mccrea M, et al. Immunization of preschool children with oral poliovirus vaccine (Sabin). JAMA 1961; 178: 693-701.
18. Sutter R, Kew O, Cochi S, Aylward RB. Poliovirus vaccine-live. In: Paul O, Orenstein W, Plotkin S, eds. Vaccines. 6th ed. China: Elsevier/Saunders, 2013: 598-645.
19. Chen RT, Hausinger S, Dajani AS, et al. Seroprevalence of antibody against poliovirus in inner-city preschool children: implications for vaccination policy in the United States. JAMA 1996; 275: 1639-45.
20. Zurbriggen S, Tobler K, Abril C, et al. Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl Environ Microbiol 2008; 74: 5608-14.
21. Mueller JE, Bessaud M, Huang QS, et al. Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina. Appl Environ Microbiol 2009; 75: 1395-401.
22. Pavlov DN. Poliovirus vaccine strains in sewage and river water in South Africa. Can J Microbiol 2006; 52: 717-23.
23. Patti AM, Santi AL, Fiore L, et al. Environmental surveillance of poliovirus in Italy: pilot study. Ann Ig 2003; 15: 97-105.
24. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012; 8: e1002599.